General information


Revenue (in thousands of €)



Laboratorios Rubió is a company that is currently undergoing a process of expansion and growth. In the last 5 years, the continued advances are an indication of the hard work put in, and the implementation of a strategy (2015-2019) that shifts the focus towards identifying new business segments, opening new markets and signing distribution agreements with other companies in the pharmaceutical sector.

In 2018, revenue reached € 40,9 million, which is 17,1% more than in 2017. By market, the increase in Spain was one of 22%, with 1,9% growth in exports.

If we compare 2018 with the 2015 period, the increase in revenue is 35,9%, with 41,6% corresponding to the national market, and 18,2% to the international market.

The growth we hope to achieve in 2019 is 9,2%, which is brought about by sales in the national market.



The company’s staff is made up of 150 people—11,3% more than in 2015—with the greatest amount of growth happening in the sales and industrial operations departments.

Laboratorios Rubió is a company that places its trust in the people who make up its organisation, recognises their professional value and dedicates resources to ensure that a good working environment is maintained by fostering opportunities, personal development and a good work-life balance.


In the last 5 years, including the 2018 budget, total investment reached € 10,8 million, of which € 5.8 million are industrial investments, € 834 thousand have been invested in to IT and new technology and € 4,88 million into different projects such as the development of new pharmaceutical formulations, sales agreements in Europe and the USA, and the LiposCale.

Investments (in thousands of €)